Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Active not recruiting 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 1Other 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Smoldering Multiple Myeloma 1Prostatic Neoplasms 1Overweight 1Obesity 1Neoplasm Metastasis 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Endometrial Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 603Cyclophosphamide 545Magnetic Resonance Spectroscopy 527Radiotherapy 513Specimen Handling 505Nivolumab 411Cisplatin 381Carboplatin 369Biopsy 305Blood Specimen Collection 304Radiosurgery 290Paclitaxel 281Gemcitabine 271Surveys and Questionnaires 269Standard of Care 267fludarabine 263Drug Therapy 263Dexamethasone 263Bevacizumab 252venetoclax 251Oxaliplatin 209Capecitabine 199Rituximab 198Radiation 191Ipilimumab 188Fluorouracil 188durvalumab 185Doxorubicin 178Etoposide 177atezolizumab 172

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Diet, Plant-Based × 1 year × Clear all
NCT07189702 2026-04-08

BEND-MBEC

University of Rochester

Phase NA Not yet recruiting
60 enrolled
Gynecologic

Neoplasm Metastasis, Endometrial Neoplasms

NCT05471414 2026-01-22

WFPBD

Weill Medical College of Cornell University

Phase NA Active not recruiting
76 enrolled
Genitourinary

Prostatic Neoplasms

NCT06055894 2025-11-13

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

Memorial Sloan Kettering Cancer Center

Phase NA Recruiting
200 enrolled
Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

NCT04298086 2025-07-11

A Study of the Body's Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
43 enrolled
BreastOther

Breast Neoplasms, Obesity, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡